77 related articles for article (PubMed ID: 15624333)
41. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
Gascoyne RD; Adomat SA; Krajewski S; Krajewska M; Horsman DE; Tolcher AW; O'Reilly SE; Hoskins P; Coldman AJ; Reed JC; Connors JM
Blood; 1997 Jul; 90(1):244-51. PubMed ID: 9207459
[TBL] [Abstract][Full Text] [Related]
42. The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Hübner K; Fischer R; Georgii A
Virchows Arch; 1995; 426(1):37-41. PubMed ID: 7704322
[TBL] [Abstract][Full Text] [Related]
43. Rearrangement of bcl-2 genes in malignant lymphomas in Chinese patients.
Chen PM; Lin SH; Seto M; Chao SC; Chiou TJ; Hsieh RK; Lin CZ; Fan S; Tzeng CH; Ueda R
Cancer; 1993 Dec; 72(12):3701-6. PubMed ID: 8252486
[TBL] [Abstract][Full Text] [Related]
44. 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma.
Betticher DC; Zucca E; von Rohr A; Egger T; Radford JA; Ambrosetti A; Bürki K; Rufener B; Schmitz SF; Cerny T
Ann Oncol; 1996 Oct; 7(8):793-9. PubMed ID: 8922192
[TBL] [Abstract][Full Text] [Related]
45. A PCR analysis of bcl-2 gene rearrangement in nodal and extranodal non-hodgkins-lymphoma (nhl) - some unusual observations in saudi patients.
Nasrin N; Akhtar M; Ezzat A; Ali M; Sigut D; Hannan M
Int J Oncol; 1994 Oct; 5(4):901-6. PubMed ID: 21559658
[TBL] [Abstract][Full Text] [Related]
46. Gene rearrangements in follicular lymphoma among Indonesian.
Oehadian A; Koide N; Fianza PI; Fadjari TH; Sumantri R; Supandiman I; Yokochi T
Acta Med Indones; 2006; 38(2):72-6. PubMed ID: 16799206
[TBL] [Abstract][Full Text] [Related]
47. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.
Summers KE; Goff LK; Wilson AG; Gupta RK; Lister TA; Fitzgibbon J
J Clin Oncol; 2001 Jan; 19(2):420-4. PubMed ID: 11208834
[TBL] [Abstract][Full Text] [Related]
48. Apparent absence of BCL-2 rearrangement in ten Saudi follicular lymphomas: A preliminary report.
Nasrin N; Akhtar M; Ali MA; Hannan MA
Ann Saudi Med; 1994 May; 14(3):219-24. PubMed ID: 17586896
[TBL] [Abstract][Full Text] [Related]
49. Genetic alterations in B-cell non-Hodgkin's lymphoma.
Magić Z; Novković T; Cikota B; Tasić-Radić O; Tarabar O; Stamatović D
Vojnosanit Pregl; 2005 Feb; 62(2):87-96. PubMed ID: 15787160
[TBL] [Abstract][Full Text] [Related]
50. Detection of bcl-2 rearrangement in HIV-related follicular lymphoid hyperplasia.
Molina TJ; Devez F; Bigorgne C; Le Tourneau A; Joulin V; Audouin J; Diebold J
Br J Haematol; 1996 Sep; 94(4):705-8. PubMed ID: 8826897
[TBL] [Abstract][Full Text] [Related]
51. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.
Gribben JG; Freedman As; Woo SD; Blake K; Shu RS; Freeman G; Longtine JA; Pinkus GS; Nadler LM
Blood; 1991 Dec; 78(12):3275-80. PubMed ID: 1742487
[TBL] [Abstract][Full Text] [Related]
52. Role of the molecular staging and response in the management of follicular lymphoma patients.
Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
[TBL] [Abstract][Full Text] [Related]
53. [Detection of bone marrow involvement by lymphoma cells in patients with B-NHL by using flow cytometry analysis].
Wang W; Gao L; Wang LL; Li MY; Li YY; Zhao W; Xu YY; Ding Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1204-7. PubMed ID: 21129261
[TBL] [Abstract][Full Text] [Related]
54. Detection of BCL-2 gene rearrangement in follicular lymphoma by polymerase chain reaction and chemiluminescence technique.
Khalil SH; Siegrist K; Ali MA
Ann Saudi Med; 1997 Jul; 17(4):423-6. PubMed ID: 17353594
[TBL] [Abstract][Full Text] [Related]
55. CD19 selection improves the sensitivity of B cell lymphoma detection.
Pugh RE; Bitter MA; Shpall EJ; Hami LS; Wolf DM; Franklin WA
J Hematother; 1998 Apr; 7(2):159-68. PubMed ID: 9597573
[TBL] [Abstract][Full Text] [Related]
56. Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosis.
Delage R; Roy J; Jacques L; Bernier V; Delâge JM; Darveau A
Br J Haematol; 1997 Jun; 97(3):589-95. PubMed ID: 9207405
[TBL] [Abstract][Full Text] [Related]
57. Clinical implication and prognostic significance of small lymphoma cells in the peripheral blood and bone marrow of B-cell non-Hodgkin's lymphomas.
Nakano M; Kuriyama Y; Kawanishi Y; Toyama K
Leuk Lymphoma; 1993 Sep; 11(1-2):119-27. PubMed ID: 8220145
[TBL] [Abstract][Full Text] [Related]
58. Automated molecular genetic DNA analysis for detecting B-cell non-Hodgkin's lymphoma in cytologic specimens.
Ruschenburg I; Schlott T; Linke B; Reimer S; Droese M
Anal Quant Cytol Histol; 1997 Jun; 19(3):255-63. PubMed ID: 9196809
[TBL] [Abstract][Full Text] [Related]
59. Primary cutaneous B-cell lymphoma with a dermatomal distribution.
Marzano AV; Berti E; Alessi E
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):884-6. PubMed ID: 10534678
[TBL] [Abstract][Full Text] [Related]
60. Quantitative PCR detection of t(11;14) bcl-1/JH in mantle cell lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.
Di Martino S; Catapano O; Siesto SR; Di Paolo M; Pugliese S; Morelli CD; Fiorica F; Varriale E; Di Francia R; Abbadessa A
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4801-10. PubMed ID: 26744872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
